BUSINESS

• SymBio Kicks Off Japan PIII for Patient-Controlled Pain Management Drug
  June 15, 2016

• PDUFA Date Set for Jan. 31, 2017 for Daiichi Sankyo’s Nausea Drug
  June 15, 2016

• Otsuka, Acucela End Partnership on AMD Drug after Trial Data Disappoint
  June 15, 2016

• Ethical Drug Sales Up 8.1% in April: Crecon Report
  June 14, 2016

• No Higher Mortality Risk Including CV Death Observed with Alogliptin against Placebo: Takeda
  June 14, 2016

• Dave Fredrickson Tapped as Next Chief of AstraZeneca Japan
  June 13, 2016

• Takeda Looks to Join Top 10 List in Global Oncology Space in 2025
  June 10, 2016

• FY2015 Earnings Roundup - 5: 10 Firms Unveil Mid-Term Biz Plans, Many Play It Safe
  June 10, 2016

• Mitsubishi Gas Chemical, Nippon Kayaku Form JV for Antibody, Biosimilar Production
  June 10, 2016

• Takeda Gets Worldwide Rights to Theravance’s GI Drug Candidate
  June 10, 2016

• Jacques Nathan to Lead Sanofi Japan from July 1
  June 10, 2016

• AZ Japan Pres. Baertschi to Become CEO of Grünenthal in October
  June 9, 2016

• Takeda, Ultragenyx Ink Strategic Partnership on Rare Genetic Diseases
  June 9, 2016

• Shionogi to Transfer 3 Off-Patent Cancer Drugs to Nichi-Iko
  June 9, 2016

• FY2015 Earnings Roundup - 4: Generic Biz Strategies Revolving around AG Launches
  June 9, 2016

• Kaketsuken Announces Plan for Production Restart, Says Flu Vaccine Output Will Be Lower
  June 9, 2016

• Kyowa Kirin, Medgenics Team Up on Severe Pediatric IBD Treatment
  June 8, 2016

• FY2015 Earnings Roundup - 3: Japan Market Stagnates despite No Drug Price Revision, Off-Patent Brands Weigh
  June 8, 2016

• Takeda, Roivant Form Joint Venture for Women’s Health, Prostate Cancer; Takeda Transfers 2 Investigational Products
  June 8, 2016

• FY2015 Earnings Roundup - 2: New Drugs Gain Traction Overseas to Underpin Japan Makers’ Financial Results
  June 7, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 456
• 457
• 458
• 459
• 460
• 461
• 462
• 463
• 464
• …
• Next ›
• 最終 »